Placenta
Volume 29, Issue 9 , Pages 802-808 , September 2008

Placental Oxidative Stress Alters Expression of Murine Osteogenic Genes and Impairs Fetal Skeletal Formation

  • M.R. Prater

      Affiliations

    • Edward Via Virginia College of Osteopathic Medicine, 2265 Kraft Drive, Blacksburg, VA 24060, USA
    • VA-MD Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA
    • Corresponding Author InformationCorresponding author. Edward Via Virginia College of Osteopathic Medicine, 2265 Kraft Drive, Blacksburg, VA 24060, USA. Tel.: +1 (540) 231 3996; fax: +1 (540) 231 5252.
    • ,
  • C.L. Laudermilch

      Affiliations

    • VA-MD Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA
    • ,
  • C. Liang

      Affiliations

    • VA-MD Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA
    • ,
  • S.D. Holladay

      Affiliations

    • VA-MD Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA

,Accepted 22 June 2008.

References 

  1. Harvey N, Cooper C. The developmental origins of osteoporotic fracture. J Br Menopause Soc. 2004;10:14–1529
  2. Barker DJ. The fetal and infant origins of disease. Eur J Clin Invest. 1995;25:457–463
  3. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M. Review: developmental origins of osteoporotic fracture. Osteoporos Int. 2006;17:337–347
  4. Javaid MK, Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab. 2002;16:349–367
  5. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595–601
  6. Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond). 2007;113:1–13
  7. DeSesso JM. Cell death and free radicals: a mechanism for hydroxyurea teratogenesis. Med Hypotheses. 1979;5:937–951
  8. Fantel AG. Reactive oxygen species in developmental toxicity: review and hypothesis. Teratology. 1996;53:196–217
  9. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541–H550
  10. Loeken MR. Free radicals and birth defects. J Matern Fetal Neonatal Med. 2004;15:6–14
  11. Sengupta B, Uematsu T, Jacobsson P, Swenson J. Exploring the antioxidant property of bioflavonoid quercetin in preventing DNA glycation: a calorimetric and spectroscopic study. Biochem Biophys Res Commun. 2006;339:355–361
  12. Yuan B, Ohyama K, Bessho T, Uchide N, Toyoda H. Imbalance between ROS production and elimination results in apoptosis induction in primary smooth chorion trophoblast cells prepared from human fetal membrane tissues. Life Sci. 2008;82:623–630
  13. Prater MR, Laudermilch CL, Holladay SD. Does immune stimulation or antioxidant therapy reduce MNU-induced placental damage via activation of Jak-STAT and NF-κB signaling pathways?. Placenta. 2007;28:566–570
  14. Tricker AR. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev. 1997;6:226–268
  15. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ. NF-κB, p38, and stress-activated protein kinase MAP kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol. 2007;170:1511–1520
  16. Mabrouk GM, Moselhy SS, Zohny SF, Ali EM, Helal TE, Amin AA, et al. Inhibition of methylnitrosourea (MNU) induced oxidative stress and carcinogenesis by orally administered bee honey and Nigella grains in Sprague Dawely rats. J Exp Clin Cancer Res. 2002;21:341–346
  17. Platzek T, Bochert G, Pauli B, Meister R, Neubert D. Embryotoxicity induced by alkylating agents: 5. Dose-response relationships of teratogenic effects of methylnitrosourea in mice. Arch Toxicol. 1988;62:411–423
  18. Shou S, Scott V, Reed C, Hitzemann R, Stadler HS. Transcriptome analysis of the murine forelimb and hindlimb autopod. Dev Dyn. 2005;234:74–89
  19. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr. 2005;135:2299–2304
  20. Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol. 2005;145:934–944
  21. Ruiz PA, Braune A, Holzlwimmer G, Quintanilla-Fend L, Haller D. Quercetin inhibits TNF-induced NF-κB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr. 2007;137:1208–1215
  22. Wilms LC, Hollman PC, Boots AW, Kleinjans JC. Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. Mutat Res. 2005;582:155–162
  23. Kanter M, Altan MF, Donmez S, Ocakci A, Kartal ME. The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct. 2007;25:747–752
  24. Kim YJ, Bae YC, Suh KT, Jung JS. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol. 2006;72:1268–1278
  25. McGartland CP, Robson PJ, Murray LJ, Cran GW, Savage MJ, Watkins DC, et al. Fruit and vegetable consumption and bone mineral density: the Northern Ireland Young Hearts Project. Am J Clin Nutr. 2004;80:1019–1023
  26. Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M, Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol. 2004;67:1307–1313
  27. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP-1. J Cell Biochem. 2004;92:285–295
  28. Nomura T, Hata S, Kusafuka T. Suppression of developmental anomalies by maternal macrophages in mice. J Exp Med. 1990;172:1325–1330
  29. Gheorghe C, Mohan S, Longo LD. Gene expression patterns in the developing murine placenta. J Soc Gynecol Investig. 2006;13:256–262
  30. Martin P. Tissue patterning in the developing mouse limb. Int J Dev Biol. 1990;34:323–336
  31. Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta. 2003;24:575–587
  32. Dokras A, Gardner LM, Seftor EA, Hendrix MJ. Regulation of human cytotrophoblast morphogenesis by hepatocyte growth factor/scatter factor. Biol Reprod. 2001;65:1278–1288
  33. Hossain M, Irwin R, Baumann MJ, McCabe LR. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials. 2005;26:2595–2602
  34. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 1995;373:702–705
  35. Likhachev AJ, Alekandrov VA, Anisimov VN, Bespalov VG, Korsakov MV, Ovsyannikov AI, et al. Persistence of methylated purines in the DNA of various rat fetal and maternal tissues and carcinogenesis in the offspring following a single transplacental dose of N-methyl-N-nitrosourea. Int J Cancer. 1983;31:779–784
  36. Glabowski W. The protective effect of stem cell factor (SCF) on in vitro development of preimplantation mouse embryos. Ann Acad Med Stetin. 2005;51:83–93
  37. Lotinun S, Evans GL, Turner RT, Oursler MJ. Deletion of membrane-bound steel factor results in osteopenia in mice. J Bone Miner Res. 2005;20:644–652
  38. Yang J, Cummings EA, O'Connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108:644–650
  39. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy?. Semin Immunpathol. 2007;29:95–113
  40. Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S, et al. Type I interferon as a novel risk factor for endothelial progenitor cell deletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 2007;56:3759–3769
  41. Batta K, Kundu TK. Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications. Mol Cell Biol. 2007;27:7603–7614
  42. Seidah NG, Mayer G, Zaid A, Rousselet E, Nassoury N, Poirier S, et al. The activation and physiological functions of the proprotein convertases. Int J Biochem Cell Biol. 2008;[Epub ahead of print]
  43. Cheah FC, Jobe AH, Moss TJ, Newnham JP, Kallapur SG. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamniotitis model. Pediatr Res. 2008;63:274–279
  44. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med. 1999;26:107–116
  45. Boots AW, Li H, Schins RP, Duffin R, Heemskerk JW, Bast A, et al. The quercetin paradox. Toxicol Appl Pharmacol. 2007;222:89–96

PII: S0143-4004(08)00201-4

doi: 10.1016/j.placenta.2008.06.010

Placenta
Volume 29, Issue 9 , Pages 802-808 , September 2008

Article Tools

* Image Usage & Resolution